These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30471923)

  • 21. A toggle switch controls the low pH-triggered rearrangement and maturation of the dengue virus envelope proteins.
    Zheng A; Yuan F; Kleinfelter LM; Kielian M
    Nat Commun; 2014 May; 5():3877. PubMed ID: 24846574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions.
    Zheng A; Umashankar M; Kielian M
    PLoS Pathog; 2010 Oct; 6(10):e1001157. PubMed ID: 20975939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the ectodomain of the envelope protein of dengue virus type 4: expression, membrane association, secretion and particle formation in the absence of precursor membrane protein.
    Hsieh SC; Tsai WY; Nerurkar VR; Wang WK
    PLoS One; 2014; 9(6):e100641. PubMed ID: 24950216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis.
    Xie X; Yang Y; Muruato AE; Zou J; Shan C; Nunes BT; Medeiros DB; Vasconcelos PF; Weaver SC; Rossi SL; Shi PY
    mBio; 2017 Feb; 8(1):. PubMed ID: 28174309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of a linearized B-cell epitope on the pr protein of dengue virus.
    Song KY; Zhao H; Li SH; Li XF; Deng YQ; Wang HJ; Ye Q; Zhu SY; Jiang ZY; Zhang FC; Qin ED; Qin CF
    J Gen Virol; 2013 Jul; 94(Pt 7):1510-1516. PubMed ID: 23559476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of the immature dengue virus at low pH primes proteolytic maturation.
    Yu IM; Zhang W; Holdaway HA; Li L; Kostyuchenko VA; Chipman PR; Kuhn RJ; Rossmann MG; Chen J
    Science; 2008 Mar; 319(5871):1834-7. PubMed ID: 18369148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of tick-borne encephalitis virus and its neutralization by a monoclonal antibody.
    Füzik T; Formanová P; Růžek D; Yoshii K; Niedrig M; Plevka P
    Nat Commun; 2018 Jan; 9(1):436. PubMed ID: 29382836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM.
    Luo Y; Guo X; Yan H; Fang D; Zeng G; Zhou J; Jiang L
    Appl Microbiol Biotechnol; 2015 Jul; 99(14):5917-27. PubMed ID: 25822571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immature dengue virus: a veiled pathogen?
    Rodenhuis-Zybert IA; van der Schaar HM; da Silva Voorham JM; van der Ende-Metselaar H; Lei HY; Wilschut J; Smit JM
    PLoS Pathog; 2010 Jan; 6(1):e1000718. PubMed ID: 20062797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural Studies of Chikungunya Virus-Like Particles Complexed with Human Antibodies: Neutralization and Cell-to-Cell Transmission.
    Porta J; Mangala Prasad V; Wang CI; Akahata W; Ng LF; Rossmann MG
    J Virol; 2016 Feb; 90(3):1169-77. PubMed ID: 26537684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structures of immature flavivirus particles.
    Zhang Y; Corver J; Chipman PR; Zhang W; Pletnev SV; Sedlak D; Baker TS; Strauss JH; Kuhn RJ; Rossmann MG
    EMBO J; 2003 Jun; 22(11):2604-13. PubMed ID: 12773377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.
    Lok SM; Kostyuchenko V; Nybakken GE; Holdaway HA; Battisti AJ; Sukupolvi-Petty S; Sedlak D; Fremont DH; Chipman PR; Roehrig JT; Diamond MS; Kuhn RJ; Rossmann MG
    Nat Struct Mol Biol; 2008 Mar; 15(3):312-7. PubMed ID: 18264114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights into flavivirus biology: the influence of pH over interactions between prM and E proteins.
    Oliveira ERA; de Alencastro RB; Horta BAC
    J Comput Aided Mol Des; 2017 Nov; 31(11):1009-1019. PubMed ID: 29064083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A bispecific antibody effectively neutralizes all four serotypes of dengue virus by simultaneous blocking virus attachment and fusion.
    Shi X; Deng Y; Wang H; Ji G; Tan W; Jiang T; Li X; Zhao H; Xia T; Meng Y; Wang C; Yu X; Yang Y; Li B; Qin ED; Dai J; Qin CF; Guo Y
    MAbs; 2016; 8(3):574-84. PubMed ID: 26905804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial maturation: an immune-evasion strategy of dengue virus?
    Rodenhuis-Zybert IA; Wilschut J; Smit JM
    Trends Microbiol; 2011 May; 19(5):248-54. PubMed ID: 21388812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel anti-dengue monoclonal antibody recognizing conformational structure of the prM-E heterodimeric complex of dengue virus.
    Puttikhunt C; Keelapang P; Khemnu N; Sittisombut N; Kasinrerk W; Malasit P
    J Med Virol; 2008 Jan; 80(1):125-33. PubMed ID: 18041028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion.
    Yu IM; Holdaway HA; Chipman PR; Kuhn RJ; Rossmann MG; Chen J
    J Virol; 2009 Dec; 83(23):12101-7. PubMed ID: 19759134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection.
    Huang KJ; Yang YC; Lin YS; Huang JH; Liu HS; Yeh TM; Chen SH; Liu CC; Lei HY
    J Immunol; 2006 Mar; 176(5):2825-32. PubMed ID: 16493039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
    Xu M; Züst R; Toh YX; Pfaff JM; Kahle KM; Davidson E; Doranz BJ; Velumani S; Tukijan F; Wang CI; Fink K
    J Virol; 2016 Dec; 90(24):11122-11131. PubMed ID: 27707930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
    Poddar A; Ramasamy V; Shukla R; Rajpoot RK; Arora U; Jain SK; Swaminathan S; Khanna N
    BMC Biotechnol; 2016 Jun; 16(1):50. PubMed ID: 27301568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.